Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction - sprookjes - yvandenbroek - TriplyDB

Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction

Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction

http://www.wikidata.org/entity/Q24676400

about

TRAF6 autoubiquitination-independent activation of the NFkappaB and MAPK pathways in response to IL-1 and RANKL Biology of recently discovered cytokines: interleukin-17--a unique inflammatory cytokine with roles in bone biology and arthritis T6BP, a TRAF6-interacting protein involved in IL-1 signaling IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1 IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF)The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models.The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings IL-17RC: a partner in IL-17 signaling and beyond Structure and signalling in the IL-17 receptor family Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB- and PI3-kinase/Akt-dependent pathways Secukinumab for rheumatology: development and its potential place in therapy IL-17 family: cytokines, receptors and signaling Cell type- and stimulus-specific mechanisms for post-transcriptional control of neutrophil chemokine gene expression The outliers become a stampede as immunometabolism reaches a tipping point The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing Tumor necrosis factor receptor-associated factors (TRAFs)The IL-17 pathway as a major therapeutic target in autoimmune diseases Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 Intracranial delivery of interleukin-17A via adeno-associated virus fails to induce physical and learning disabilities and neuroinflammation in mice but improves glucose metabolism through AKT signaling pathway Delineation of diverse macrophage activation programs in response to intracellular parasites and cytokines.Therapeutic potential of anti-interleukin-17A aptamer: suppression of interleukin-17A signaling and attenuation of autoimmunity in two mouse models.Role of interleukin 17 in arthritis chronicity through survival of synoviocytes via regulation of synoviolin expression.Th17 cells: effector T cells with inflammatory properties.Desiccating stress promotion of Th17 differentiation by ocular surface tissues through a dendritic cell-mediated pathway.Interleukin-17 regulation: an attractive therapeutic approach for asthma TPL2 mediates autoimmune inflammation through activation of the TAK1 axis of IL-17 signaling.The differential regulation of human ACT1 isoforms by Hsp90 in IL-17 signaling Interleukin-6 (IL-6) and IL-17 synergistically promote viral persistence by inhibiting cellular apoptosis and cytotoxic T cell function SEF/IL-17R (SEFIR) is not enough: an extended SEFIR domain is required for il-17RA-mediated signal transduction.Differential requirement for c-Jun N-terminal kinase 1 in lung inflammation and host defense Evidence for ligand-independent multimerization of the IL-17 receptor.Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling.Stimulus-specific induction of a novel nuclear factor-kappaB regulator, IkappaB-zeta, via Toll/Interleukin-1 receptor is mediated by mRNA stabilization.Expression profile of immune-associated genes in nasal polyps.

P2860

Q21092160-1F13966C-EDA1-4F11-8578-7EB38D261F39 Q21195672-05A5B6FD-BA01-4401-8426-8088CB15417A Q22254711-D4708595-9CA1-472E-BB03-71479E99F79D Q24290462-F8E4A0B5-2FEB-498E-B899-2CB7102D73C1 Q24291729-603B856A-1299-4801-9E68-E4389B984F59 Q24296262-68F739B5-E3EB-4F6E-A828-FACBF1B7DF3A Q24319867-DEDC5E5C-6951-4DBD-8CB5-006C8BEE46C7 Q24519770-AB169870-D9D8-4FB9-BBAC-03121268CE77 Q24623195-4D96C619-84E9-49E8-93F9-E0F70840B49E Q24629783-A0ED787E-CAAD-4396-89E6-E2FAC2A3CC82 Q24648045-A7525F21-7944-498C-A0E9-E4CBCA86C4D9 Q24674584-58803560-47F6-4404-ADA3-D01709DC48FC Q24793443-C11AE11B-0EE9-4D33-B779-036EEDC0FDCE Q26738523-3658D39F-3CC2-4A18-9349-46058F6F34DD Q26860251-39928683-0463-403D-AD82-395AF9B63A11 Q27004287-1859FA3C-AE76-4F75-ACF1-E82A908A8EC5 Q27005951-7A72729F-72AF-4818-B22A-A2FC4C672999 Q27687800-D53FD0AA-CDC6-4E2B-AE98-F33C3A1F07F6 Q28199382-A8306D63-1AF2-48CC-8BDD-EC6752EF9E3C Q28300826-70C543BF-568F-43DC-810B-59154371F5D4 Q28395248-9972C066-15DD-4DD4-AE78-EA7E4320521F Q28589412-E190BC9C-7087-417B-8B6E-936580D69265 Q28943518-39972BF4-E553-4066-984B-4F2CA0E86CD5 Q29547855-AFCF5225-B3C3-48B1-A5BB-1F7E5F32FD10 Q30724821-650D2CAC-3C26-4E6E-985C-FAEC979A5299 Q33548768-E2681292-D7C6-42F5-9979-F4C6F28B281E Q33725862-BA98A400-8DA5-4F5E-AF28-F051C62AF81B Q33728533-7696E931-E665-4650-9A8F-49D56C880CF2 Q33732092-2396E0F8-6AB9-429E-B748-916355DE761B Q33938235-26961856-92DF-46A3-B57D-A66D4A103732 Q33951731-39D7A16C-9E4A-4A8C-95E4-0AD1CBF32A9A Q33964282-A94E6A59-2074-4EC2-9058-E385E5855687 Q33992530-001326D8-5F5E-4977-B3DC-8DC7DC0214D2 Q34057935-7AD00761-9229-48F2-A070-C7AFF1739361 Q34236471-045CFE2B-FA34-4379-8C8C-E8BBC3440CAF Q34238642-CDDAC397-C7C1-47D6-8BD6-0F33C49D1E02 Q34279731-18AC4291-6E0D-4637-8F75-9CCB12BDD092 Q34340648-2BD14D93-6DDB-4337-A929-5DBFCA811BE6 Q34364544-ACB73228-D051-4AF8-8FF4-4B4F80429722 Q34542514-6A9EAEB0-E638-4F5B-A6D2-49145F797472

P2860

Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction

http://www.wikidata.org/entity/Q24676400

description

2000 nî lūn-bûn

@nan

2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Requirement of tumor necrosis ...... rleukin 17 signal transduction

@ast

Requirement of tumor necrosis ...... rleukin 17 signal transduction

@en

Requirement of tumor necrosis ...... rleukin 17 signal transduction

@nl

type

label

Requirement of tumor necrosis ...... rleukin 17 signal transduction

@ast

Requirement of tumor necrosis ...... rleukin 17 signal transduction

@en

Requirement of tumor necrosis ...... rleukin 17 signal transduction

@nl

prefLabel

Requirement of tumor necrosis ...... rleukin 17 signal transduction

@ast

Requirement of tumor necrosis ...... rleukin 17 signal transduction

@en

Requirement of tumor necrosis ...... rleukin 17 signal transduction

@nl

P1433

Q24676400-C16F505C-C2BF-43ED-8148-9C6797782D8E

P1476

Q24676400-8FECF72D-E9E2-41A6-B251-FFDAFE24788C

P2093

Q24676400-2DF9462E-2C16-41C9-AB62-24DE4296701E

Q24676400-8F5A5710-7281-44B1-B966-2FFDD7ECD4E3

Q24676400-F6E1BE45-8A9A-451E-ADE9-AFBF90B29035

P2860

Q24676400-01DA77BD-3F0F-4849-8162-399E8C1F50EB

Q24676400-01EDA0A4-DE23-47A5-9E84-44D2BA0A8221

Q24676400-058B8F41-3DFC-45D7-A258-9C16FC3A567D

Q24676400-0B58C9C3-E563-4A40-B83A-76036561BBB9

Q24676400-0D88794A-B5B3-46B2-B97C-9654C8EBBA58

Q24676400-11AE04A2-EAFE-4516-A17F-ED054385858E

Q24676400-12E82575-756E-4052-B1D0-E107E15DEEE0

Q24676400-14A45A00-FAA4-4E1D-B3E2-ABA3B9DDA77C

Q24676400-1EAA19F5-E037-4039-99F9-215B7391C593

Q24676400-1F7C1A6F-B05D-4144-9D8B-D96E173F1173

P304

Q24676400-9D55EE37-0655-4392-A2BB-2B2649461963

P31

Q24676400-19501A01-C675-4752-B349-B5A5C68D2F3B

P3181

Q24676400-35ACED08-1B6B-4855-B89E-88968F29554B

P356

Q24676400-BED13DD1-4947-4418-9965-34E5B1432CEA

P407

Q24676400-7E046B12-4063-4504-9669-8FD2EB809FA4

P433

Q24676400-B778AB4A-414A-4E87-8024-C20128C65E02

P478

Q24676400-37BFD99F-CCB3-487D-BA55-6E3F9604D8E8

P577

Q24676400-C7A5394C-61F1-4D68-B539-FB5F3F935751

P5875

Q24676400-F2F2DB5A-467B-4334-AC0D-6B11276D9616

P698

Q24676400-E52AEBAC-507E-446A-AEAD-B3093A52793D

P921

Q24676400-182687a7-8551-4a7e-8a9d-661795a3b3f3

P932

Q24676400-53CDC4D3-9046-403B-8EE2-BC782EFBB40B

P3181

P356

P1433

Journal of Experimental Medicine

P1476

Requirement of tumor necrosis ...... rleukin 17 signal transduction

@en

P2093

K Yamaguchi

http://www.w3.org/2001/XMLSchema#string

R Schwandner

http://www.w3.org/2001/XMLSchema#string

Z Cao

http://www.w3.org/2001/XMLSchema#string

P2860

Human IL-17: a novel cytokine derived from T cells

A novel RING finger protein interacts with the cytoplasmic domain of CD40

The NF-kappa B and I kappa B proteins: new discoveries and insights

CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene

IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex

TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways

A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB

IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK

IRAK: a kinase associated with the interleukin-1 receptor

TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex

P304

1233-40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

519089

http://www.w3.org/2001/XMLSchema#string

P356

10.1084/JEM.191.7.1233

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

191

http://www.w3.org/2001/XMLSchema#string

P577

2000-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12568597

http://www.w3.org/2001/XMLSchema#string

P698

10748240

http://www.w3.org/2001/XMLSchema#string

P921

P932

2193168

http://www.w3.org/2001/XMLSchema#string